AGP Picks
View all

Wellness Today St. Kitts & Nevis
Provided by AGP

Wellness Today St. Kitts & Nevis: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Today St. Kitts & Nevis.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 9, 2026

AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
Jun. 9, 2026

AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology

Indeterminate GlobeNewswire
International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje
Jun. 9, 2026

International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje

Indeterminate GlobeNewswire
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
Jun. 9, 2026

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

Indeterminate GlobeNewswire
Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
Jun. 9, 2026

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

Indeterminate GlobeNewswire
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
Jun. 9, 2026

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Indeterminate GlobeNewswire
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases
Jun. 9, 2026

Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

Indeterminate GlobeNewswire
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
Jun. 9, 2026

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Indeterminate GlobeNewswire
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
Jun. 9, 2026

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire
PRM and Project Endo Launch National University Health Initiative to Improve Early Endometriosis Recognition on College Campuses
Jun. 9, 2026

PRM and Project Endo Launch National University Health Initiative to Improve Early Endometriosis Recognition on College Campuses

Indeterminate GlobeNewswire
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
Jun. 9, 2026

ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation

Indeterminate GlobeNewswire
Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022
Jun. 9, 2026

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

Indeterminate GlobeNewswire
SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team
Jun. 9, 2026

SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team

Indeterminate GlobeNewswire
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
Jun. 9, 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Indeterminate GlobeNewswire
The MUHC Foundation’s Le Bal Rouge Gala raises $2,223,306 million to accelerate discovery in health care at the MUHC’s Glen site
Jun. 9, 2026

The MUHC Foundation’s Le Bal Rouge Gala raises $2,223,306 million to accelerate discovery in health care at the MUHC’s Glen site

Indeterminate GlobeNewswire
Le gala Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2 223 306 $ pour accélérer les découvertes en santé au site Glen du CUSM
Jun. 9, 2026

Le gala Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2 223 306 $ pour accélérer les découvertes en santé au site Glen du CUSM

Indeterminate GlobeNewswire
zSpace Technology Powers Breakthrough 3D Thyroid Reconstruction Research in Italy
Jun. 9, 2026

zSpace Technology Powers Breakthrough 3D Thyroid Reconstruction Research in Italy

Indeterminate GlobeNewswire
Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 Tournament
Jun. 9, 2026

Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 Tournament

Indeterminate GlobeNewswire
Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
Jun. 9, 2026

Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program

Indeterminate GlobeNewswire
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 
Jun. 9, 2026

Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 

Indeterminate GlobeNewswire
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
Jun. 9, 2026

Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Wellness Today St. Kitts & Nevis

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.